Article info
Abstracts Accepted for Publication
Psoriatic arthritis
AB0729 Baseline Levels of CTX-II and Glucosyl-Galactosyl-Pyridinoline in Patients Wih Early Psoriasic Arthritis: Association with Disease Severity,Disability, Quality-of-Life, Biological Treatment Required and Progression of Joint Destruction at 5 Years of Follow Up
Citation
AB0729 Baseline Levels of CTX-II and Glucosyl-Galactosyl-Pyridinoline in Patients Wih Early Psoriasic Arthritis: Association with Disease Severity,Disability, Quality-of-Life, Biological Treatment Required and Progression of Joint Destruction at 5 Years of Follow Up
Publication history
- First published July 15, 2016.
Online issue publication
July 15, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2016, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions